FDA Inspection 1204466 — Patheon Pharmaceuticals Inc.
The FDA completed an inspection of Patheon Pharmaceuticals Inc. on April 21, 2023 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cincinnati, OH (United States)